BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Early pregnancy factor
,
Doxycycline
,
rs4950928
,
SNCA
,
Response to oxidative stress
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
AMG531
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
The role of AMG-531 in the treatment of thrombocytopenia in idiopathic thrombocytopenic purpura and …
Romiplostim (AMG531, Nplate) for secondary failure of platelet recovery after allo-SCT.
High doses of romiplostim induce proliferation and reduce proplatelet formation by human megakaryocy…
AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl.
Thrombopoietin factors.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia
Study of AMG531(Romiplostim) in Patients With Aplastic Anemia
Study of AMG531 (Romiplostim) in Patients With Aplastic Anemia
Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia
Long Term Follow-up Observational Study After Clinical Trials of AMG531 (Romiplostim) in Patients Wi…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ